Open AccessBiological therapy safety in chronic inflammatory arthropathy patients
Author(s) -
Udi Nussinovitch,
Shiri Rubin,
Yair Levy,
Merav Lidar,
Avi Livneh
Publication year - 2020
Publication title -
european journal of rheumatology :/european journal of rheumatology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2147-9720
pISSN - 2148-4279
DOI - 10.5152/eurjrheum.2019.19074
Subject(s) - medicine , qt interval , cardiology , repolarization , long qt syndrome , sudden cardiac death , sudden death , electrophysiology
The marketing of biological therapies transformed the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. But there is still concern about patient safety and management in daily clinical practice. The aim of this study was to estimate risk factors of the adverse effects in a cohort of Spanish patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.